Cover Image
市場調查報告書

中國阿茲海默症治療藥物市場

Alzheimer Disease Drugs Markets in China

出版商 Asia Market Information & Development 商品編碼 86316
出版日期 內容資訊 英文 239 Pages
訂單完成後即時交付
價格
Back to Top
中國阿茲海默症治療藥物市場 Alzheimer Disease Drugs Markets in China
出版日期: 2016年05月01日 內容資訊: 英文 239 Pages
簡介

中國的阿茲海默症治療藥物需求在過去10年間急速上升。今後5年間其生產、需求應該也會順利的持續上升吧。

此報告書詳細調查了中國阿茲海默症治療藥物市場的投資環境、產業發展、需求與供給、產業結構、市場通路、主要企業等,還提供了的實績、的長期預測。報告書之內容摘要如下所示。

第1章 說明

  • 本調查書的範圍與方法論
  • 摘要

第2章 商業環境

  • 經濟展望
    • 主要經濟指標
    • 工業生產額
    • 人口以及勞動力
    • 來自海外的投資
    • 海外貿易
  • 金融以及稅金規定
    • 銀行制度以及規定
    • 外國貨幣兌換
    • 稅金、關稅以及海關

第3章 阿茲海默症治療藥物產業評價

  • 產業結構
  • 市場規模
  • 市場成長促進要因
  • 營業額
  • 主要製造業者的設備據點以及營業額
  • 主要製造業者的市場佔有率
  • 勞動成本
  • 具有潛在性的投入企業
  • 主要流通企業
  • 主要來自海外的投資
  • 技術開發

第4章 阿茲海默症治療藥物的生產以及需求

  • 概要
  • 地區別需求
  • 營業額以及進口量
    • Ginkgo Bilota Extract
    • Breviscapine
    • Ganglioside
    • Donepezil
    • Galanthamine
    • Nicergoline
    • Rivastigmine
    • Memantine
    • Huperzine A
    • Oxiracetam
    • Flunarizine
    • Piracetam
    • 其他
  • 價格動向

第5章 阿茲海默症治療藥物的市場展望

  • 市場展望
  • 政府規定
  • 醫療保險產業展望
  • 消費者支出動向
  • 人口動態
  • 醫療產業動向
  • 醫院以及病床
  • 醫師以及到家出診

第6章 市場戰略

  • 中國市場投入概要
    • 流通系統
    • 阿茲海默症治療藥物的流通通路
    • 運輸以及輸送基盤建設
    • 通訊
  • 對中國市場的投入
    • 對中國出口
    • 間接出口
    • 直接出口
    • 許可以及合作製造
    • 中國內組合
    • 合作製造
    • 貿易許可
    • 投資
    • 資本合作
    • 共同合作
    • 完全外資企業

第7章 阿茲海默症治療藥物製造業者目錄

  • 製造業者簡介
  • 流通業者以及貿易公司
  • 協會以及研究機關
  • 主要終端使用者

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 801

China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Alzheimer's Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Alzheimer's Disease Drugs by Region
  • Alzheimer's Disease Drugs Sales Volume
  • Ginkgo Bilota Extract
  • Breviscapine
  • Ganglioside
  • Donepezil
  • Galanthamine
  • Nicergoline
  • Rivastigmine
  • Memantine
  • Huperzine A
  • Oxiracetam
  • Flunarizine
  • Piracetam
  • Other Alzheimer's Disease Drugs
  • Alzheimer's Disease Drugs Imports
  • Ginkgo Bilota Extract Imports
  • Breviscapine Imports
  • Ganglioside Imports
  • Donepezil Imports
  • Galanthamine Imports
  • Nicergoline Imports
  • Rivastigmine Imports
  • Memantine Imports
  • Huperzine A Imports
  • Oxiracetam Imports
  • Flunarizine Imports
  • Piracetam Imports
  • Other Alzheimer's Disease Drugs Imports
  • Pricing Trend

V. ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK

  • Alzheimer's Disease Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends By Region
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

V. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. ALZHEIMER'S DISEASE DRUGS PRODUCER DIRECTORY

  • Major Alzheimer's Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Associations and Research Institutes
  • Major End-Users

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Alzheimer's Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investments

IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

  • Total Alzheimer's Disease Drugs Sales Volume
  • Alzheimer's Disease Drugs Major Producer and Their Market Share
  • Ginkgo Bilota Extract Major Producer and Their Market Share
  • Breviscapine Major Producer and Their Market Share
  • Ganglioside Major Producer and Their Market Share
  • Donepezil Major Producer and Their Market Share
  • Galanthamine Major Producer and Their Market Share
  • Dihydroergotamine Major Producer and Their Market Share
  • Rivastigmine Major Producer and Their Market Share
  • Memantine Major Producer and Their Market Share
  • Huperzine A Major Producer and Their Market Share
  • Oxiracetam Major Producer and Their Market Share
  • Flunarizine Major Producer and Their Market Share
  • Piracetam Major Producer and Their Market Share
  • Alzheimer's Disease Drugs Import

V. ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK

  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Alzheimer's Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China's Imports and Exports

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Sales Volume

II. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

  • Alzheimer's Disease Drugs Sales Volume
  • Worldwide Alzheimer's Disease Drugs Demand by Region
  • Ginkgo Bilota Extract Sales Volume and Market Share
  • Breviscapine Sales Volume and Market Share
  • Ganglioside Sales Volume and Market Share
  • Donepezil Sales Volume and Market Share
  • Galanthamine Sales Volume and Market Share
  • Dihydroergotamine Sales Volume and Market Share
  • Rivastigmine Sales Volume and Market Share
  • Memantine Sales Volume and Market Share
  • Huperzine A Sales Volume and Market Share
  • Oxiracetam Sales Volume and Market Share
  • Flunarizine Sales Volume and Market Share
  • Piracetam Sales Volume and Market Share
  • Other Alzheimer's Disease Drugs Sales volume and market share
  • Alzheimer's Disease Drugs Import Volume
  • Ginkgo Bilota Extract Import Volume and Market Share
  • Breviscapine Import Volume and Market Share
  • Ganglioside Import Volume and Market Share
  • Donepezil Import Volume and Market Share
  • Galanthamine Import Volume and Market Share
  • Dihydroergotamine Import Volume and Market Share
  • Rivastigmine Import Volume and Market Share
  • Memantine Import Volume and Market Share
  • Huperzine A Import Volume and Market Share
  • Oxiracetam Import Volume and Market Share
  • Flunarizine Import Volume and Market Share
  • Piracetam Import Volume and Market Share
  • Other Alzheimer's Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel
Back to Top